DURHAM, N.C., Sept. 27, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) will showcase for the first time its DERMACYTE oxygen-rich skin care products at the Spa & Resort/Medical Aesthetics Spa Conference and Expo at the Jacob K. Javits Convention Center in New York City starting tomorrow. The conference is open to the public from 10 AM to 5 PM on September 28-29, 2010. Free DERMACYTE Oxygen Concentrate samples will be available while supplies last at our Booth #5020.
About the ConferenceThe Spa & Resort/Medical Aesthetics Expo ( www.spaandresortexpo.com) gives spa, aesthetic and wellness professionals the tools to move their spa business forward with incomparable networking opportunities and hands-on training and discovery of the most cutting-edge products, treatments, and services available in the industry today. Skin care and rejuvenation, mineral make-up, tanning products, robes and linens, aromatherapy, injectables, as well as nutritious food and beverages and spa apparel are just some of the products and services on display. Attendees include spa/medical aesthetics owners and professionals, estheticians, dermatologists, dentists, plastic surgeons, wellness practitioners, nutritionists and holistic therapists. Attendees at the conference can also register for the HBA Global Expo & Conference, which takes place at the same location September 29-30. HBA Global Expo & Conference ( www.hbaexpo.com) is the largest product development event for the cosmetics, personal care, skin care, fragrance and wellness industries and features more than 600 educational and exhibitor partners. Exhibitors include international suppliers of raw materials and ingredients, packaging materials, dispensing systems, private label and contract manufacturers and testing equipment. The three-day conference program is renowned for providing cutting-edge information on the latest industry trends, new product developments, marketing and branding know-how, as well as the latest in naturals, packaging design, global distribution, and technical advancements. About Oxygen Biotherapeutics, Inc. Oxygen Biotherapeutics, Inc. is developing medical and cosmetic products that efficiently deliver oxygen to tissues in the body. The Company has developed a proprietary perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product called Oxycyte® that is being formulated for both intravenous and topical delivery for conditions including but not limited to traumatic brain injury, decompression sickness and topical wounds, as well as for personal skin care. More information is available at www.oxybiomed.com. The Oxygen Biotherapeutics, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7277 The DERMACYTE logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7792 Caution Regarding Forward-Looking Statements This news release contains certain forward-looking statements by the company that involve risks and uncertainties and reflect the company's judgment as of the date of this release. These statements include those referring to the plans for the expansion of the DERMACYTE product line and the timing of the introduction of those new products. Matters beyond the company's control could lead to delays in the new product introductions and customer acceptance of these new products. Furthermore, there can be no assurance that such plans will lead to meaningful sales of DERMACYTE or generate any revenue for the company. The company disclaims any intent or obligation to update these forward-looking statements beyond the date of this release. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
CONTACT: Oxygen Biotherapeutics, Inc. Ellen Corliss, Vice President Corporate Communications & Investor Relations 919-855-2112